Clinical Trial Update: A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male Patients [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial completed evaluating the efficacy of Ramosetron in male patients with diarrhea-predominant irritable bowel syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome Diarrhea Predominant

Drugs mentioned

• Ramosetron (ramosetron)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Irritable Bowel Syndrome | Phase 4 | Status: COMPLETED